#26. Steve Axelrod: Wirelessly Monitoring the GI Tract at G-Tech Medical

Wirelessly Monitoring the GI Tract at G-Tech Medical

 

Steve Axelrod, PhD, President & CEO, G-Tech Medical

Fogarty-0889 300px.jpg

Steve received his Ph.D. from Yale in Elementary Particle Physics and did his post-doc in the same field at Stanford. He worked at Measurex-Honeywell for 15 years where he was Director of Measurement System and Hardware Engineering. In 2003 he entered the medical device field, and helped develop and commercialize the Xoft Axxent microTube and radiation therapy delivery system. Steve has led teams delivering numerous best in class systems and devices in both medical devices and industrial automation. Some examples are nuclear basis weight, X-ray and infrared absorption sensors, Large scanning frames, fast high channel count data acquisition systems, skin and vaginal applicators for radiation therapy, high precision measurement systems for characterizing and testing system and device performance. Steve has been CEO of G-Tech since November 2011. This project combines his experience leading high performance R&D teams, his passion for medical devices and his expertise in creating sophisticated measurement systems.


#25. Jonathan Coe: Making the Switch from Engineer to CEO at Prescient

Making the Switch from Engineer to CEO at Prescient

 

Jonathan Coe, Co-Founder, President & CEO, Prescient Surgical

Jonathan Coe-17-2S.jpg

With more than a decade of experience in the medical device industry, Jon is both an inventor and a leader. Before co-founding Prescient Surgical as a Stanford Biodesign Innovation Fellow, Jon held a range of roles in engineering, marketing, and leadership in the surgical instrument divisions of Johnson & Johnson and Covidien. He is an inventor on 25 issued patents and successfully launched four major products in bariatric, general, and natural orifice surgery, and surgical oncology. He also started two interventional cardiology companies, Metavention and Gradient Therapeutics, and led the IP, technical, and pre-clinical efforts at Metavention through a successful Series B investment. Jon holds SB and MS degrees in Mechanical Engineering from MIT and Georgia Tech, respectively.

#24. Shubhra Jain: How We Invest at Cota Capital

How We Invest at Cota Capital

 

Shubhra Jain, MD, Senior Associate, Cota Capital

Shubhra.png

Dr. Shubhra Jain joined Cota in 2018 as a Senior Associate where she is responsible for sourcing, executing and analyzing healthcare investments. Prior to Cota, Shubhra was Associate Director of Commercial Strategy and Corporate Development at Natera where she focused on Biopharma Partnerships, the diligence of potential acquisitions, market research and competitive positioning. Prior to Natera, she led Product management for Acute care suite of products at Pieces Technologies where she led product development and launch of SaaS risk surveillance and prediction solutions for clinical outcomes and published peer-reviewed research on the subject. Prior to Pieces, Dr. Jain served as a consultant and an advisor to several health tech startups and Fortune 500 companies.

Dr. Jain is a Primary Care Physician from India, has her Masters in Engineering from Stanford with a major in Biodesign and her MBA from the Wharton School of Business.

#23. Ryan Pierce: How to Get Funded

How to Get Funded

 

Ryan Pierce, Co-Founder and CEO, Nine, & Lecturer in Bioengineering, Stanford

pierce headshot.jpg

This is a recording of a live event. View the presentation deck

Ryan Pierce is Co-Founder and CEO of Nine, Entrepreneur-in-Residence at Rock Health, and Lecturer in Bioengineering at Stanford, where he teaches BIOE 70Q: Medical Device Innovation. He has served as VP of Design and Innovation at Ventus Medical, VP of Business Development at Loma Vista Medical, a healthcare investor at De Novo Ventures, and a product designer at Concentric Medical and The Foundry/Zephyr Medical. An inventor on over two dozen issued U.S. patents, he has designed FDA-cleared devices to treat sleep apnea and stroke. Ryan holds mechanical engineering degrees from MIT and Stanford, and an MBA from Harvard Business School.

#22. Mike Harrison: Pioneering Fetal Surgery

Pioneering Fetal Surgery

 
harrison_lrg.jpg

Michael R. Harrison, MD

Principal Investigator & Clinical Lead, UCSF-Stanford Pediatric Device Consortium

Professor Emeritus of Surgery, Pediatrics, Obstetrics, Gynecology & Reproductive Sciences, UCSF

Director Emeritus, UCSF Fetal Treatment Center

Since retiring from active clinical practice in 2006, Dr. Harrison has dedicated his time and research efforts to the PDC, including mentoring junior innovators and trainees and advancing his own device development projects. As the Program Director and Clinical Lead, he oversees PDC activities, strategic aims, and clinical collaborations.

Dr. Harrison has extensive experience in clinical problem-solving and device development, initially in pioneering the field of fetal surgery at UCSF. For more than 25 years, he has studied how life-threatening fetal abnormalities alter normal physical processes. Fetal intervention required the invention of many new techniques and devices, including the development of absorbable staples to open and close the gravid uterus and the development of the Harrison fetal bladder stent for obstructive uropathy. This stent was the first device to receive FDA designation as a Humanitarian Use Device and is widely used around the world.

Earlier in his career, Dr. Harrison developed other novel devices and surgical tools, including a cell microculture harvesting device for automating mixed lymphocycte cultures while a research associate at the NIH. More recently, he has developed devices that rely on magnetic force to solve pediatric problems, two of which are currently in first-in-human trials.

In addition to his role with the PDC, Dr. Harrison is Professor Emeritus of Surgery, Pediatrics, Obstetrics, Gynecology, and Reproductive Sciences and Director Emeritus of the Fetal Treatment Center at UCSF.

#21. Gene DeJuan: Lessons from Founding ForSight Labs

Lessons from Founding ForSight Labs

 

Gene DeJuan, Jr., MD, Founder & Vice-Chairman, ForSight Labs

#21. EugeneDeJuan-circle.jpg

Renowned retinal surgeon, inventor and entrepreneur Dr. Eugene de Juan, Jr., serves as Vice-Chairman of ForSight Labs, where he participates as an active inventor and advisor in early-stage ophthalmic device opportunities.

Dr. de Juan, Jr., splits his time between ForSight Labs and UCSF. He holds the “Jean Kelly Stock Distinguished Chair” in Ophthalmology. UCSF recruited Dr. de Juan for this special role to augment translation of the many ideas being developed within the academic center. He continues to see patients, operate and teach at UCSF.

Dr. de Juan, Jr., has participated in the development of a number of ophthalmology’s most exciting new technologies with over 100 products and the founding of nine venture funded companies including Second Sight, InnoRx, NeoVista, and Retina Labs, in addition to ForSight Labs’ first five “VISION” companies: Transcend Medical, Inc., founded in 2005; VISION2 (acquired by QLT, Inc. in 2007); Nexis Vision, Inc. (formerly ForSight VISION3, Inc.), founded in 2007; ForSight VISION4, Inc., founded in 2009; and ForSight VISION5, Inc., founded in 2010.

Prior to moving to San Francisco, Dr. de Juan, Jr., was a professor of ophthalmology at the University of Southern California and CEO of the Doheny Eye Institute, focusing on innovative techniques for treating blinding retinal disorders through retinal transplantation, macular translocation, robotic surgery, retinal implants, and other new procedures, medicines and instruments.

Prior to these positions, Dr. de Juan served at the Wilmer Eye Institute at Johns Hopkins University School of Medicine, where he was Co-Director of Vitreoretinal Service, Director of the Microsurgery Advanced Design Laboratory (MADLAB) and Joseph E. Green Professor of Ophthalmology. From 1983 to 1992, he was a member of the medical staff of the Duke University Eye Center, holding joint teaching appointments with the departments of ophthalmology and cell biology.

He is a passionate supporter of ophthalmic education and development and has recently helped established a chair for Ophthalmic Education at Johns Hopkins University.

Dr. de Juan completed his medical degree and internship training at the University of South Alabama College of Medicine. He served an internship at University of South Alabama Medical Center followed by a residency at the Wilmer Ophthalmological Institute in Baltimore, MD, and a fellowship in vitreoretinal surgery at Duke University. He holds patents on over sixty medical devices and is responsible for more than 250 academic publications.

#20. Joe Urban: Detecting Acute Kidney Injury at Potrero Medical

Detecting Acute Kidney Injury at Potrero Medical

 

Joe Urban, CEO, Potrero Medical

#20 Joe Urban.jpg

Potrero Medical, Inc. is a predictive health company transforming patient care using predictive analytics for early detection of critical illnesses. As a spinout of medical device incubator Theranova LLC, Potrero Medical was founded with a mission to improve patient care with the latest advances in artificial intelligence and machine insights. Potrero Medical is headquartered in San Francisco, CA. For more information, visit www.potreromed.com or follow on LinkedIn.

#19. Amanda French: Smart Birth Control at Cadence Digital

Smart Birth Control at Cadence Digital

 

Amanda French, Co-Founder and CEO, Cadence Digital

Amanda French.png

Amanda is the co-founder and CEO of Cadence Digital – a reproductive health company focused on empowering women to understand and control their birth control. She was a 2016-2017 Innovation Fellow at the Stanford Byers Center for Biodesign. Amanda began her career at Edwards Lifesciences, where through the Technical Development Program she gained experience in R&D, program management, manufacturing, and marketing. She quickly caught the innovation bug, and enjoyed developing breakthrough technology as an R&D engineer with Edwards’ Advanced Technology teams as well as at Earlens. Amanda holds a BS in mechanical engineering from Duke University. When she is not working, she enjoys cooking, yoga, and contemporary dance.

#18. Carl Schoellhammer: Innovating in Drug Delivery at Suono Bio

Innovating in Drug Delivery at Suono Bio

 

Carl Schoellhammer, Founder and COO, Suono Bio

schoelhammer.jpg

A former student of MIT professor Robert Langer, Carl invented a pill that can inject drugs directly into the gastrointestinal tract. His mPill is a small plastic devices covered with tiny needles and a protective coating that dissolves. The invention, platform technology to deliver therapeutic molecules independent of formulation, helped him win the prestigious Lemelson-MIT Student Prize.

About Suono Bio

Suono Bio is developing therapeutic products for inflammatory-mediated diseases leveraging their ultra-rapid and formulation independent delivery technology. Suono Bio’s platform enables rapid, localized delivery of small molecules, biologics, and nucleic acids and gene therapies without the need for encapsulation of the therapeutic. Suono is a portfolio company of the Rosenman Institute’s VC fund, Medtech Venture Partners.

#17. Alex Tilson: Pivoting with Advanced Materials at Loma Vista Medical

Pivoting with Advanced Materials at Loma Vista Medical

Alex Tilson, CEO & Founder, Loma Vista Medical & Neptune Medical

 
alex tilson.jpeg

Alex Tilson is the founder and CEO of Neptune Medical. Alex has spent the last twenty- five years leading high performance teams that build innovative, world-class products, including solar powered race vehicles (Stanford University, across the U.S. 2x and across Australia), film industry animatronic special effects (Edge Innovations (‘Free Willy’ and ‘Anaconda’)), surgical robotics (Intuitive Surgical), products for interventional cardiology (Guidant), implantable coronary devices (Converge Medical), extended wear hearing aids (InSound Medical), and high performance composite medical balloons (Loma Vista Medical). He is a Stanford mechanical engineer and earned an MBA from Harvard. Alex is an avid cyclist (nine major tours, including across Asia and 4x across North America), and a competitive distance runner (Olympic Trial marathoner and former American 50k record holder (http://www.hogue.com/svclassic/index2002.html)).

#16. Russ Branaghan: How to Use FDA's Guidance on Human Factors

How to Use FDA's Guidance on Human Factors

Russ Branaghan, President & Chief Scientist, Research Collective

 

Download the slide deck that Russ used while giving this talk.

Russ-450px.jpg

Dr. Russell J. Branaghan is founder and scientific advisor at Research Collective. Russ enjoys teaching, mentoring and research as a Professor of Cognitive Psychology and Human Factors at Arizona State University and as a long-standing Visiting Professor at Northwestern University. Russ is also integrated in the human factors arena, where he currently serves as Chair of the Human Factors and Ergonomics Society Product Design Technical Group, on the Editorial Board of the Journal of Human Factors, and on the Advisory Board for Mayo Clinic’s Center for Innovation. An avid researcher and writer, Russ has authored over 40 articles and one book. He also served an appointment as the Managing Editor of User Experience Magazine. With over 20 years of industry experience and consulting to over half of the Fortune 100, Russ brings his expertise and vision to Research Collective.

#15. Dan Burnett: Starting Medtech Companies at the TheraNova Incubator

Starting Medtech Companies at the Theranova Incubator

Daniel Burnett, MD, CEO & Founder, Theranova

 
Burnett-Dan-600x900.jpg

Dr. Burnett received his M.D. from Duke University and concurrently obtained an M.B.A. from Duke’s Fuqua School of Business. Since 2006 Dr. Burnett has raised, or helped raise, over $100MM for the seven TheraNova spinouts- BAROnova, Sequana Medical (formerly Novashunt), Velomedix, EMKinetics, Channel Medsystems, Potrero Medical, and Consano Medical. He is an inventor on 15 issued patents and over 200 patents pending worldwide. He recently joined University of California San Francisco as an entrepreneur in residence with QB3 and as adjunct faculty in the Bioengineering Department.

#12. David Kim: Changing the Healthcare Ecosystem at DigiTx Partners

Changing the Healthcare Ecosystem at DigiTx Partners

David Kim, MD, CEO, DigiTx Partners

 
david-kim.png

David is the CEO of DigiTx Partners, bringing both business and clinical expertise to venture capital with an extensive background practicing medicine and building healthcare software companies. Most recently, Dr. Kim served as the COO of Lumiata, a venture-backed predictive analytics company positioned at the intersection of data science and medical science. Prior to Lumiata, he spent over a decade as an investor evaluating and growing healthcare companies at MPM Capital and Pinnacle Ventures. Before entering the business sector, David practiced as a general internist and hospitalist at Kaiser South San Francisco where he also served as the Director of Urgent Care and Assistant Chief of Internal Medicine. David completed his internal medicine residency at Harbor-UCLA Medical Center and is a graduate from the Johns Hopkins University School of Medicine (M.D), Stanford Graduate School of Business (M.B.A.), and Pomona College (B.A., Biology). In addition to leading the DigiTx fund, David serves as an active advisor to the Catalyst Program within the UCSF Clinical & Translational Science Institute.